Bedaquiline: A New Hope to Treat Multi-Drug Resistant Tuberculosis

E-ISSN： 1873-4294|14|16|1866-1874

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.14, Iss.16, 2014-08, pp. : 1866-1874

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment and Prevention of Multidrug-Resistant Tuberculosis

By Bastian I. Colebunders R.

Drugs, Vol. 58, Iss. 4, 1999-10 ,pp. : 633-661

Adis International

Access to resources Recommend Favorite

Comparison of the Pharmacokinetics of Two Dosage Regimens of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis Patients

By Alffenaar Jan-Willem C.

Clinical Pharmacokinetics, Vol. 49, Iss. 8, 2010-08 ,pp. : 559-565

Adis International

Access to resources Recommend Favorite

Pharmacokinetics and tissue distribution studies of orally administered nanoparticles encapsulated ethionamide used as potential drug delivery system in management of multi-drug resistant tuberculosis

By Kumar Gaurav Sharma Sadhna Shafiq Nusrat Pandhi Promila Khuller Gopal Krishan Malhotra Samir

Drug Delivery, Vol. 18, Iss. 1, 2011-01 ,pp. : 65-73

Informa Healthcare

Access to resources Recommend Favorite

New antibacterial agents for treating infections caused by multi-drug resistant Gram-negative bacteria

By O'Neill AJ

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 3, 2008-03 ,pp. : 297-302

Informa Healthcare

Access to resources Recommend Favorite

Clinical Pharmacology and Lesion Penetrating Properties of Second- and Third-Line Antituberculous Agents Used in the Management of Multidrug-Resistant (MDR) and Extensively-Drug Resistant (XDR) Tuberculosis

Current Clinical Pharmacology, Vol. 5, Iss. 2, 2010-05 ,pp. : 96-114

Bentham Science Publishers

Access to resources Recommend Favorite